Jammu to pioneer India’s first Cannabis Medicine Project

The ‘Cannabis Research Project’ of CSIR-IIIM Jammu, spearheaded by Prime Minister Narendra Modi, marks the first-ever initiative of its kind in India. This groundbreaking project is carried out in partnership with a Canadian firm ‘IndusScan’ with the aim of harnessing the potential of cannabis, a substance known for its abuse potential, for the benefit of humanity, particularly for patients afflicted with neuropathies, cancer, and epilepsy.

The Historic Collaboration Between CSIR-IIIM and IndusScan

The historic scientific agreement signed between CSIR-IIIM and IndusScan holds immense significance not only for J&K but also for the entire nation. It has the potential to revolutionize medicine production, ensuring that the country can produce and export medicines that were previously sourced from foreign countries.

This project will play a significant role in raising awareness about the diverse medicinal applications of this once-abused substance, particularly in providing relief to patients suffering from malignancies and various other diseases.

From the perspective of Atma-Nirbhar Bharat (self-reliant India), once all the necessary approvals are obtained, this initiative will enable the production of high-quality drugs suitable for treating different types of neuropathies, diabetic pains, and more, fostering self-sufficiency in the pharmaceutical sector.

CSIR-IIIM: Pioneering Scientific Research in India

CSIR-IIIM, the oldest scientific research institute in India, boasts a rich history of groundbreaking discoveries, including the identification of mint in the 1960s and its pivotal role in the purple revolution. Now, with the advent of the Cannabis Research Project, CSIR-IIIM is poised to elevate its status even further, cementing its position as a prestigious hub for scientific research in India.

Advancements in Medical Cannabis

Cannabis, a remarkable plant, has led to the approval of several drugs by the FDA, including Marilnol/nabilone and Cesamet, prescribed for managing nausea and vomiting. Sativex is another FDA-approved drug that utilizes cannabis for treating neuropathic pain and spasticity, while Epidiolex, containing Cannabidiol, has shown promising results in treating epilepsy. Furthermore, cannabis is being utilized for various medical purposes in other countries as well.

Key takeaways for competitive examinations

  • Chief Scientist at CSIR-IIIM Jammu: Dr Zabeer Ahmed

Find More Miscellaneous News Here

Recent Posts

Meet the World’s Youngest Self-Made Woman Billionaire Luana Lopes Lara

In an age where technology and finance intersect at lightning speed, Luana Lopes Lara, a…

26 mins ago

Australia’s Victoria University to Open First India Campus in Gurugram by 2026

In a significant development for higher education in India, Victoria University (VU) from Australia is…

27 mins ago

Which Lake is known as the Lake of Tears? Know the Name

Many lakes around the world are known by special names because of their stories, beauty,…

33 mins ago

RBI Monetary Policy December 2025: Why India Cut Rates and What It Means for the Economy

Under Section 45ZL of the Reserve Bank of India Act, 1934, every quarter, India’s Monetary…

41 mins ago

National Conservation Programmes in India: Protecting Tigers, Dolphins, Elephants, Bears, Crocodiles and More

India hosts nearly 8% of the world’s biodiversity, making conservation crucial for ecological balance and…

1 hour ago

Swaraj Kaushal, Former Mizoram Governor Passes Away at 73

Swaraj Kaushal, the former Governor of Mizoram, a noted senior advocate, and the husband of…

1 hour ago